@article{75d3804b04cd4773a06162cd204b1286,
title = "Arterial stiffness and atrial fibrillation recurrence: another risk marker or a call for better management of concomitant disease?",
author = "{de Groot}, {J. R.} and D. Linz",
note = "Funding Information: J.R. de Groot has received research grants through his institution from Atricure, Bayer, Boston Scientific, Daiichi Sankyo, Johnson & Johnson and Medtronic, and honoraria/speaker{\textquoteright}s fees from AtriCure, Bayer, BIOTRONIK, CardioVasculair Onderwijs Instituut, Daiichi Sankyo, Medtronic, Novartis and Servier. D. Linz has received research grants through his institution from Bayer and Biosense Webster, and honoraria/speaker{\textquoteright}s fees from Daiichi Sankyo, Medtronic, BIOTRONIK, Respicardia and Itamar Medical.",
year = "2022",
month = apr,
doi = "https://doi.org/10.1007/s12471-022-01678-8",
language = "English",
volume = "30",
pages = "187--189",
journal = "Netherlands heart journal",
issn = "1568-5888",
publisher = "Bohn Stafleu van Loghum",
number = "4",
}